Showing results (151-160 of 178) with videos related to
Sort By:
Pageof 18
Chemmedchem|April 8, 2009
Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitorsTania Castaño, Huanchen Wang, Nuria E Campillo, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 16, 2020
Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational toolsVictor Sebastian-Perez, Alfonso García-Rubia, Sayed H Seif El-Din, et al.Journal of Medicinal Chemistry|January 8, 2025
Modulation of Mitochondria-Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis ModelMikel Etxebeste-Mitxeltorena, Hector Flores-Romero, Sandra Ramos-Inza, et al.Journal of Medicinal Chemistry|May 27, 2017
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic DiseasesValle Palomo, Daniel I Perez, Carlos Roca, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2015
Defects in subventricular zone pigmented epithelium-derived factor niche signaling in the senescence-accelerated mouse prone-8Paola Castro-Garcia, María Díaz-Moreno, Carmen Gil-Gas, et al.Neuropharmacology|December 13, 2025
Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathyMarta Gomez-Almeria, Loreto Martinez-Gonzalez, Ana Teresa Matos, et al.Journal of Medicinal Chemistry|April 6, 2023
N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic ProfileAlfonso Garcia-Rubia, Fátima Lasala, Tiziana Ginex, et al.Journal of Medicinal Chemistry|September 30, 2014
Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitorsAna M García, José Brea, Jose A Morales-García, et al.Journal of Medicinal Chemistry|January 3, 2022
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis TherapyVanesa Nozal, Loreto Martínez-González, Marta Gomez-Almeria, et al.Clinical Nutrition (Edinburgh, Scotland)|November 29, 2016
Towards a multidisciplinary approach to understand and manage obesity and related diseasesStephan C Bischoff, Yves Boirie, Tommy Cederholm, et al.Pageof 18